Expression of minichromosome maintenance 5 protein in proliferative and malignant skin diseases

International Journal of Dermatology

Volumn 46, Issue 11, 2007, Pages 1171-1176

  Liu, Houjun ^a,b   Takeuchi, Satoshi ^b   Moroi, Yoichi ^b   Lin, Nengxing ^a   Urabe, Kazunori ^b   Kokuba, Hisashi ^b   Imafuku, Shinichi ^b   Dainichi, Teruki ^b   Uchi, Hiroshi ^b   Furue, Masutaka ^b   Tu, Yating ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; MINICHROMOSOME MAINTENANCE PROTEIN; MINICHROMOSOME MAINTENANCE PROTEIN 5; UNCLASSIFIED DRUG;

ARTICLE; BASAL CELL CARCINOMA; BOWEN DISEASE; BOWENOID PAPULOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; EPIDERMIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PSORIASIS; SKIN CANCER; SKIN CARCINOMA; SKIN DISEASE; SQUAMOUS CELL CARCINOMA;

BOWEN'S DISEASE; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CELL CYCLE PROTEINS; CELL NUCLEUS; EPIDERMIS; HUMANS; IMMUNOHISTOCHEMISTRY; PROLIFERATING CELL NUCLEAR ANTIGEN; PSORIASIS; SKIN; SKIN DISEASES; SKIN NEOPLASMS;

EID: 35848956356     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2007.03335.x     Document Type: Article

References (26)

1. Tanaka T, Knapp D, Nasmyth K. Loading of an Mcm protein onto DNA replication origins is regulated by Cdc6p Cdks. Cell 1997; 90: 649-660.
2. Aparicio OM, Weinstein DM, Bell SP. Components and dynamics of DNA replication complexes in S. cerevisiae: Redistribution of MCM proteins and Cdc45p during S phase. Cell 1997; 91: 59-69.
3. Romanowski P, Madine MA. Mechanisms restricting DNA replication to once per cell cycle: MCMS, pre-replicative complexes and kinases. Trends Cell Biol 1996; 6: 184-188.
4. Lee JK, Hurwitz J. Processive DNA helicase activity of the minichromosome maintenance proteins 4 2001 January 2, 6, and 7 complex requires forked DNA structures. Proc Natl Acad Sci USA 2001; 98: 54-59.
5. Blow JJ, Hodgson B. Replication licensing - defining the proliferative state? Trends Cell Biol 2002; 12: 72-78.
6. Sato M, Gotow T, You Z, et al. Electron microscopic observation and single-stranded DNA binding activity of the Mcm4,6,7 complex. J Mol Biol 2000; 300: 421-431.
7. Stoeber K, Tlsty TD, Happerfield L, et al. DNA replication licensing and human cell proliferation. J Cell Sci 2001; 114: 2027-2041.
8. Toschi L, Bravo R. Changes in cyclin/proliferating cell nuclear antigen distribution during DNA repair synthesis. J Cell Biol 1988; 107: 1623-1628.
9. Scholzen T, Gerdes J. The Ki-67 protein: From the known and the unknown. J Cell Physiol 2000; 182: 311-322.
10. Daidone MG, Silvestrini R. Prognostic and predictive role of proliferation indices in adjuvant therapy of breast cancer. J Natl Cancer Inst Monogr 2001; 30: 27-35.
11. Hall PA, Levison DA, Woods AL, et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990; 162: 285-294.
12. Brown DC, Gatter KC. Monoclonal antibody Ki-67: Its use in histopathology. Histopathology 1990; 17: 489-503.
13. Hiraiwa A, Fujita M, Nagasaka T, et al. Immunolocalization of hCDC47 protein in normal and neoplastic human tissues and its relation to growth. Int J Cancer 1997; 74: 180-184.
14. Hiraiwa A, Fujita M, Adachi A, et al. Specific distribution patterns of hCDC47 expression in cutaneous diseases. J Cutan Pathol 1998; 25: 285-290.
15. Todorov IT, Werness BA, Wang HQ, et al. HsMCM2/BM28: A novel proliferation marker for human tumors and normal tissues. Lab Invest 1998; 78: 73-78.
16. Murphy N, Ring M, Heffron CC, et al. Quantitation of CDC6 and MCM5 mRNA in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix. Mod Pathol 2005; 18: 844-849.
17. Going JJ, Keith WN, Neilson L, et al. Aberrant expression of minichromosome maintenance proteins 2 and 5, and Ki-67 in dysplastic squamous oesophageal epithelium and Barrett's mucosa. Gut 2002; 50: 373-377.
18. Williams GH, Swinn R, Prevost AT, et al. Diagnosis of oesophageal cancer by detection of minichromosome maintenance 5 protein in gastric aspirates. Br J Cancer 2004; 91: 714-719.
19. Brake T, Connor JP, Petereit DG, et al. Comparative analysis of cervical cancer in women and in a human papillomavirus-transgenic mouse model: identification of minichromosome maintenance protein 7 as an informative biomarker for human cervical cancer. Cancer Res 2003; 63: 8173-8180.
20. Semple JW, Duncker BP. ORC-associated replication factors as biomarkers for cancer. Biotechnol Adv 2004; 22: 621-631.
21. Murphy N, Ring M, Heffron CC, et al. p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer. J Clin Pathol 2005; 58: 525-534.
22. Stoeber K, Swinn R, Prevost AT, et al. Diagnosis of genito-urinary tract cancer by detection of minichromosome maintenance 5 protein in urine sediments. J Natl Cancer Inst 2002; 94: 1071-1079.
23. Heenen M, Thiriar S, Noel JC, et al. Ki-67 immunostaining of normal human epidermis: Comparison with 3H-thymidine labelling and PCNA immunostaining. Dermatology 1998; 197: 123-126.
24. Liu HJ, Urabe K, Moroi Y, et al. Expression of p16 and hTERT Protein is associated with the presence of high-risk human papillomavirus in Bowenoid papulosis. J Cutan Pathol 2006; 33: 551-558.
25. Goodwin EC, DiMaio D. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Proc Natl Acad Sci USA 2000; 97: 12513-12518.
26. Leone G, DeGregori J, Yan Z, et al. E2F3 activity is regulated during the cell cycle and is required for the induction of S phase. Genes Dev 1998; 12: 2120-2130.